NIMG-21. INTERIM ANALYSIS OF A PHASE II STUDY OF MULTIPARAMETRIC MR-GUIDED HIGH-DOSE RESPONSE-ADAPTIVE RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Authors: Michelle Kim, Madhava Aryal, Benjamin Rosen, Hemant Parmar, Daekeun You, Larry Junck, Denise Leung, Yoshie Umemura, Jason Heth, Wajd Al-Holou, Todd Hollon, Daniel Wahl, Theodore Lawrence, Yue Cao

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.639

Source: Full article

NIMG-21. INTERIM ANALYSIS OF A PHASE II STUDY OF MULTIPARAMETRIC MR-GUIDED HIGH-DOSE RESPONSE-ADAPTIVE RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Abstract